Covid-19 Updates

CureVac shares tank 50% after preliminary data shows Covid vaccine is only 47% effective

In this article 5CV-DE CureVac stock plunged 50% in extended trading Wednesday after the German biopharmaceutical company released preliminary efficacy results for its Covid-19 vaccine candidate that failed to meet success criteria. The vaccine candidate demonstrated an interim efficacy of 47% against Covid-19 disease “of […]